
New independent clinical study shows safety and efficacy of GC Aesthetics’ PERLE breast implants
-GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions to the global healthcare market, We announced that our implant, PERLE™, was recently featured in an independently peer-reviewed paper published in the Aesthetic Surgery Journal Open…

ObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners
ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm. ObjectiveHealth is an innovator in clinical research, seamlessly integrating clinical trials…

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development
a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. Under the program,…

Isaac Health Raises $5.7M to End Dementia Care Deserts and Build the Future of Brain Health Care Delivery
Oversubscribed Seed round led by Meridian Street Capital and B Capital Isaac Health, a digital health company emerging as a national leader for brain health, announced today the successful completion of its oversubscribed $5.7 million Seed round. The round was…

Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023. “I am pleased to announce that…

New Independent Clinical Study Demonstrates Safety and Effectiveness of GC Aesthetics PERLE Breast Implant
GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, is proud to announce that its PERLE™ breast implant is featured in a recent independent peer-reviewed article in the Aesthetic Surgery Journal…

In a Usability Analysis of the ArthroFree® Wireless Surgical Camera by Lazurite®, More than 90% of Respondents Agree the Absence of Cables Will Have a Positive Impact on Efficiency and Patient Safety
Medical device and technology company Lazurite® announced that a new article just published in the Journal of Orthopaedic Experience & Innovation provides key support for the usability of the company’s ArthroFree® wireless surgical camera. In a human factors usability analysis of the…

Pathos AI Completes Acquisition of Rain Oncology
Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acquire…

BioConsortia Extends Nitrogen-fixing Microbial Products Beyond Cereals to Vegetables and Other Markets
Field trial results confirm nitrogen-fixing microbial seed treatment products increased yields and reduced fertilizer use in vegetable crops like potatoes -BioConsortia, Inc., a leading agricultural technology company that designs and licenses advanced microbial products to reduce the ecological impacts of…

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
Navidea Biopharmaceuticals, Inc. announced today the filing of Form 15 to voluntarily deregister and suspend SEC reporting obligations. The company maintains strategic focus on its Fix, Fund, Propel approach. Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a company…

London North West University Healthcare NHS Trust Finds Digital Way Forward with PhenoTips’ Genomic Health Record
-London North West University Healthcare NHS Trust (LNWH) unites multiple geographically distinct hospitals with PhenoTips’ cloud-hosted Genomic Health Record (GHR) to digitize genomics and deliver on “Our Way Forward” 5-year plan. LNWH’s ambitious 5-year strategy, “Our Way Forward”, will see…

IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time…
